Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

rumors

Ariad Joins Rumor Mill: Hope May Trump Reality

Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) is joining the ranks of the next big biotech acquisitions. At least so goes the rumor mill. Ariad fits the bill of many biotech acquirers ...
Read Full Story »
Monkey evil

Top Analyst Downgrades, Stocks to Sell: Apple, Twitter, First Solar and More

It is the first full trading week of 2014, and investors are trying to decide how to position their portfolios for the year. Wall Street brokerage firms are making their ...
Read Full Story »
Monkey evil

Top Analyst Upgrades and Downgrades: BlackBerry, Five Below, Micron, Tiffany and More

Stocks are challenging new highs going into Christmas and year-end, and investors have to be positioning their portfolios for 2014 and beyond. 24/7 Wall St. reviews many Wall Street analyst ...
Read Full Story »
2014 in the box

Cowen Forecasts Top 10 Potential Biotech Surprises for 2014

All of the major firms on Wall Street we cover have prognostications and stock picks for 2014. The Cowen biotechnology team has a list of top 10 surprises that are ...
Read Full Story »
investing

Nuance and ARIAD Are Volume Movers for Very Different Reasons

Nearly 39 million shares of Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) have traded hands as of 11:30 a.m. Tuesday morning, nearly triple the stock's average daily volume of around 14 million ...
Read Full Story »
Pills

Shire, Novartis Deals: Pharmaceutical Shakeups Continue

The wave of mergers and acquisitions in health care continues with two big announcements Monday. Drug maker Shire PLC (NASDAQ: SHPG) will acquire the rare disease biopharmaceutical company ViroPharma (NASDAQ: ...
Read Full Story »
170622870

Ariad Going to Hell in a Handbasket

Things just keep getting worse for Ariad Pharmaceuticals Inc. (NASDAQ: ARIA). In fact, a series of shareholder revolts are probably in the works here after yet another massive drop on ...
Read Full Story »
Bull and Bear

Top Analyst Downgrades, Stocks to Sell: Ariad, Goodyear, Myriad, Kellogg and More

Stocks are at all-time highs now that a deal has been reached in Washington, D.C., and investors have to wonder which stocks are set to keep rising and which ones ...
Read Full Story »
biotech

pSivida, Alimera and Ariad Join Bio-Implosion Watch

Biotech and emerging health care technology companies both fit into a high-stake poker match on Wall Street. Investors can earn exponential rewards if they are right, or they can lose ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Ariad, Hecla, HP, Micron and More

Earnings season has officially started, but the stock market and bond market are both dealing with the government shutdown, an upcoming debt ceiling and even the announcement of a new ...
Read Full Story »
Food and Drug Administration logo

FDA Hold on Ariad Kills $2 Billion in Value (Updated)

Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) is getting crushed on Wednesday due to a clinical hold placed by the U.S. Food & Drug Administration. The company confirmed that the FDA has ...
Read Full Story »
biotech

Top Biotechs Set to Win in the War on Cancer

Tuesday saw the wrap up of the 2013 European Society of Medical Oncology (ESMO) conference in Amsterdam, which featured key data from several of the companies covered by the biotech ...
Read Full Story »
biotech

Cowen’s Eight Biotech Stocks to Buy That Could Beat Earnings: Alexion, Ariad and More

Biotechnology stocks have had an extremely solid first half of the year. The analysts at Cowen Group point out that expectations are very high and many of the stocks have ...
Read Full Story »
biotech

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

On Friday after the market closed, biotech giant Amgen Inc. (NASDAQ: AMGN) made an unsolicited $120 per share bid for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) that was rejected. The company ...
Read Full Story »
Bull and Bear

Top 12 Analyst Upgrades and Downgrades (ASTM, ARIA, BIIB, LULU, NKE, RYAAY, UA, UTX, VHS, VFC, MS, GS)

Investors and traders are constantly looking for new ideas that will generate profits. 24/7 Wall St. looks over research calls from all over to find great ideas, from value stocks ...
Read Full Story »